Loading...
287 Japan Disease Specific Drugs Reports
Country Covered: Japan
Study Period: 2018 - 2029
Major Players: Takeda, AstraZeneca, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: Sanofi, Eli Lilly and Company, Pfizer Inc., AstraZeneca, Johnson And Johnson
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: Merck & Co. Inc., Bayer AG, Amgen Inc, AstraZeneca, Johnson & Johnson Services, Inc.
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: AbbVie Inc., Pfizer Inc., Teva Pharmaceutical, Sun Pharmaceutical Industries Ltd, Novartis AG
Country Covered: Japan
Study Period: 2018 - 2029
Major Players: Astrazeneca, Boehringer Ingelheim, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Aventis
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: Stryker Corporation, Zimmer Biomet Holdings Inc, CONMED Corporation, Arthrex Inc, Medtronic PLC
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: Sanofi, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., AstraZeneca
Country Covered: Japan
Study Period: 2021 - 2029
Major Players: AbbVie Inc., Bristol Myers Squibb Company, F Hoffmann-La Roche Ltd, Gilead Sciences Inc., Merck KGaA
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: 3M Company , ACell Inc. , BSN medical , Cardinal Health , ConvaTec Inc.
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: 3M Company, Becton, Dickinson and Company, Biomerieux SA, Sterigenics International LLC, Johnson and Johnson(Ethicon)
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: 3M, Blistex Inc., Colgate- Palmolive Company, Church & Dwight, Inc., GSK plc
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: Smith & Nephew , Johnson & Johnson, Mölnlycke Health Care AB, 3M Company, Cardinal Health
Country Covered: Japan
Study Period: 2021 - 2029
Major Players: DJO Global, Inc. , Teikoku Pharma USA, Inc, Zimmer Biomet , 3M, AKSIGEN
Country Covered: Japan
Study Period: 2021 - 2029
Major Players: Philips, Colgate, DMG Dental, VOCO GmbH, Dentsply Sirona
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: Alcon Inc., Bausch Health Companies Inc., Johnson & Johnson, Carl Zeiss Meditec AG, Topcon Corporation
Country Covered: Japan
Study Period: 2024 - 2029
Major Players: Johnson & Johnson, Sanofi SA, GlaxoSmithKline PLC, F. Hoffmann-La Roche Ltd. (Genentech Inc.), Leti Pharma
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: Allergan, Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Lupin Pharmaceuticals, Inc., Pfizer Inc.
Country Covered: Japan
Study Period: 2021 - 2029
Major Players: Dermamed Solutions, AbbVie Inc (Allergan, Inc), Obagi Cosmeceuticals LLC, Merz GmbH & Co. KGaA, L'Oréal SA
Country Covered: Japan
Study Period: 2021 - 2029
Major Players: Santen Pharmaceutical Co. Ltd, OASIS Medical, Alcon Inc., Bausch Health Companies Inc., AbbVie Inc. (Allergan PLC)
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: Amgen, Inc., Teva Pharmaceuticals Industries Ltd., Novartis AG, G1 Therapeutics, BeyondSpring Pharmaceuticals Inc
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: Teva Pharmaceutical Industries Ltd, Johnson & Johnson, Pfizer Inc, Merck & Co Inc, AbbVie Inc. (Allergan)
Country Covered: Japan
Study Period: 2021 - 2029
Major Players: Johnson & Johnson, Novartis AG, Bausch Health, Santen Pharmaceutical Co., Ltd., AbbVie Inc.
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: Medtronic PLC, Astellas Pharma, Inc., Macleods Pharmaceuticals Ltd, Pfizer, Inc, AbbVie Ltd.
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: AbbVie Inc. (Allergan, Inc.), Merck & Co., Inc.,, Novartis AG, Bausch Health Companies Inc. , Johnson & Johnson
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: Takeda Pharmaceutical Company Limited , Bristol-Myers Squibb, LUPIN, Accord Healthcare, Otsuka America Pharmaceutical, Inc.
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: AbbVie Inc , Gilead Sciences, Inc, Mylan N.V, Alaxia, Vertex Pharmaceuticals Incorporated
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: Novartis AG, AbbVie Inc., Aciont Inc., Amgen, Tarsier Pharma Ltd
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: AbbVie Inc., Allergan PLC, AstraZeneca Plc, GlaxoSmithKline Plc, Janssen Pharmaceuticals Inc.
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: Eli Lilly and Company, Pfizer Inc., Johnson and Johnson (Janssen Global Services, LLC), Novartis AG, Amgen Inc.
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: Boehringer Ingelheim International GmbH, UCB SA, Novartis AG, Teva Pharmaceutical, Merck & Co Inc.